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Operant behavior is not only regulated by factors related to the quality or quantity of
reinforcement, but also by the work requirements inherent in performing instrumental
actions. Moreover, organisms often make effort-related decisions involving economic
choices such as cost/benefit analyses. Effort-based decision making is studied using
behavioral procedures that offer choices between high-effort options leading to relatively
preferred reinforcers vs. low effort/low reward choices. Several neural systems, including
the mesolimbic dopamine (DA) system and other brain circuits, are involved in regulating
effort-related aspects of motivation. Considerable evidence indicates that mesolimbic
DA transmission exerts a bi-directional control over exertion of effort on instrumental
behavior tasks. Interference with DA transmission produces a low-effort bias in animals
tested on effort-based choice tasks, while increasing DA transmission with drugs such
as DA transport blockers tends to enhance selection of high-effort options. The results
from these pharmacology studies are corroborated by the findings from recent articles
using optogenetic, chemogenetic and physiological techniques. In addition to providing
important information about the neural regulation of motivated behavior, effort-based
choice tasks are useful for developing animal models of some of the motivational
symptoms that are seen in people with various psychiatric and neurological disorders
(e.g., depression, schizophrenia, Parkinson’s disease). Studies of effort-based decision
making may ultimately contribute to the development of novel drug treatments for
motivational dysfunction.
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BEHAVIORAL ECONOMICS, CHOICE AND THE NEURAL
REGULATION OF MOTIVATED BEHAVIOR
It is something of a truism that the field of economics is not about money, but rather, it is
about choice. As it turns out, much of the study of motivation is also about understanding
the neural basis of choice, which ultimately means that economic concepts and approaches
can enlighten and inform research on the neurobiology of motivation (Salamone et al.,
2016a,c, 2017). There is a rich literature on behavioral economics that has emerged from
the field of experimental behavior analysis (e.g., Hursh and Winger, 1995; Bickel et al.,
2000; Madden et al., 2000, 2007), which has provided useful terms and methods that can aid
neuroscientists. For example, the results of some instrumental behavioral experiments, including
those focusing on drug reinforcers, can be analyzed by quantative economic methods such as
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demand curves (Hursh and Winger, 1995; Heyman, 2000;
Salamone et al., 2009; Madden and Kalman, 2010; Heinz et al.,
2012; Bentzley et al., 2013, 2014; Bentzley and Aston-Jones,
2015).
According to the classical view of the reinforcement of
instrumental behavior, a reinforcer is a stimulus that strengthens
a response. Thus, a positive reinforcer is a stimulus that, when
presented after a response, increases the probability or frequency
of that response (Skinner, 1953). However, there are additional
views of reinforcement that also are necessary to understand
in order to explicate the deeper significance of this process.
Positive reinforcers are typically motivational stimuli that the
organism is likely to approach, or seeking to attain, and which
would tend to occur with a relatively high probability in an
unconstrained environment (Thorndike, 1911; Premack, 1959;
Salamone and Correa, 2002). Furthermore, viewed from the
perspective of economics, a reinforcer is a good or commodity,
or an object or activity that has relatively high value. Given this
background, what is an instrumental behavior such as pressing
a lever, running in a maze, or pressing a computer keyboard?
According to economic principles, an instrumental behavior is
the labor that is exchanged for the good or commodity (i.e., the
reinforcer). Thus, positively reinforced behavior is essentially
a barter system, in which the organism trades its work for
access to the reinforcer (Rachlin, 2003; Salamone et al., 2009).
It therefore appears that instrumental response requirements are
the price (i.e., the response cost) that needs to be paid in order to
obtain access to motivationally relevant stimuli that are serving
as reinforcers.
There is no shortage of articles in behavioral neuroscience
that focus on ‘‘reward’’ or ‘‘reward value’’ or ‘‘outcome
valuation’’. The dopamine (DA) hypothesis of ‘‘reward’’ has
been a ubiquitous feature of psychopharmacology and behavioral
neuroscience for decades (e.g., but see also Salamone et al., 2007
and Nicola, 2016 for problems with this hypothesis). Decision
making studies in animal subjects and human participants that
investigate the impact of reinforcers differing in quality or
quantity, or factors such as reinforcement delay or probability,
have contributed greatly to our understanding of the neural
regulation of motivated behavior (Floresco, 2015; Wassum and
Izquierdo, 2015; Winstanley and Floresco, 2016). Nevertheless,
it can be argued that the study of the other side of the
equation, the labor or cost side, is equally important (Salamone
and Correa, 2012; Wassum and Izquierdo, 2015; Salamone
et al., 2016a,c; Winstanley and Floresco, 2016). To this end,
several laboratories including our own have been focusing
on the neural regulation of choice based upon exertion of
physical effort. The work performed in order to obtain access
to reinforcing stimuli is itself an important factor in regulating
instrumental behavior, one which should not be subsumed or
hidden under the general umbrella of ‘‘reward value’’, but rather
should receive its own spotlight. It is not as though the brain
merely functions to assess the value of stimuli, and the actions
necessary to obtain those stimuli are just some epiphenomena.
It trivializes the neural regulation of instrumental behaviors
to consider them merely as a small part of the ‘‘rewarding
outcome’’, when in fact they are the actions that lead to
the outcome. Importantly, there is considerable evidence that
manipulations affecting brain functions, such as drugs or lesions,
can dissociate the exertion of effort in instrumental behavior
from reinforcement value based upon preference (Salamone
et al., 2016a,c, 2017). The present review will discuss some of this
research, with a particular focus on the role of forebrain circuits
and neurotransmitters such as DA, adenosine and GABA.
Furthermore, this review will briefly describe how research on
effort-based choice behavior can lead to the development of
animal models that are useful for understanding aspects of
psychopathology.
EFFORT-RELATED CHOICE AND
NUCLEUS ACCUMBENS DA
Conceptual Background
The processes involved in initiating and sustaining instrumental
actions, including the exertion of effort needed to overcome
obstacles and obtain access to motivationally relevant stimuli,
are necessary for survival. However, a complex environment
can involve potential access to several different reinforcers,
and distinct paths for accessing them. For these reasons,
organisms must make choices involving several factors, including
cost/benefit assessments based upon work requirements and
reinforcement preference (Salamone and Correa, 2002, 2012;
Walton et al., 2006; Salamone et al., 2007, 2016a,b,c; Winstanley
and Floresco, 2016). Considerable evidence indicates that
nucleus accumbens DA, along with other transmitters and
structures, participates in the neural circuitry that regulates
effort-based choice behavior (Salamone et al., 2007, 2009,
2016a,b,c; Floresco et al., 2008a; Hauber and Sommer, 2009; Mai
et al., 2012; Floresco, 2015; Winstanley and Floresco, 2016). The
effects of interfering with DA transmission have been assessed
in many ways (Salamone et al., 2016a,b,c), including systemic
or intracranial injections of DA antagonists, local depletions
of accumbens DA with injections of the neurotoxic agent
6-hydroxydopamine (6-OHDA), or systemic administration of
the DA depleting agent tetrabenazine, which blocks vesicular
storage by inhibiting the type-2 vesicular monoamine transporter
(VMAT-2). Moreover, various pharmacological, genetic, and
optogenetic methods have been used to determine the effects of
augmenting DA transmission.
T-Maze Choice Procedures
One of the procedures that has been used to assess the
contribution of accumbens DA to response allocation and effort-
related choice behavior is a T-maze barrier choice procedure
developed by Salamone et al. (1994). With this procedure, the
two choice arms of the maze can have different reinforcement
densities (e.g., 4 vs. 2 food pellets, or 4 vs. 0), and under
some conditions a vertical barrier is placed in the arm with
the higher density of food reinforcement to present an effort-
related challenge. Under conditions in which the high-density
arm (4 pellets) had the barrier in position, and the arm without
the barrier contained an alternative food source (2 pellets), DA
depletions or antagonism substantially alter effort-based choice,
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decreasing selection of the high-density arm, while increasing
choice of the low-density arm with no barrier (Salamone et al.,
1994; Cousins et al., 1996; Denk et al., 2005; Mott et al.,
2009; Yohn et al., 2015a,b). The T-maze barrier choice task
has undergone considerable behavioral validation and evaluation
(Salamone et al., 1994; Cousins et al., 1996; van den Bos et al.,
2006; Ostrander et al., 2011; Pardo et al., 2012; Yohn et al.,
2015a,b). If there is no barrier obstructing the arm with the high
reinforcement density, rats mostly choose that arm, and neither
D1 or D2 family antagonists, nor accumbens DA depletions,
nor tetrabenazine alter arm choice (Salamone et al., 1994; Yohn
et al., 2015a,b). When the arm with the barrier contains 4 pellets,
but the other arm contains no pellets, and thus the only way
to obtain food is to climb the barrier, rats with DA depletions
still choose the high-density arm, climb the barrier, and eat the
pellets (Cousins et al., 1996; Yohn et al., 2015a). In a mouse study,
although the DA antagonist haloperidol produced a low-effort
bias when the high reward arm had a barrier, it had no effect on
choice when both arms had a barrier in place (Pardo et al., 2012).
Thus, interference with DA transmission did not alter preference
for the high density of food reward over the low density, did not
affect discrimination or reference memory processes related to
arm preference, and did not produce an absolute impairment in
the ability to climb the barrier.
Lever Pressing Choice Procedures
Another commonly used task for assessing effort-based choice
is the concurrent lever pressing/chow feeding procedure. With
this task, rats are offered the option of either lever pressing to
obtain a relatively preferred food (e.g., Bio-serv pellets; usually
obtained on a fixed ratio 5 (FR5) schedule), or approaching and
consuming a less preferred food (lab chow) that is concurrently
available in the chamber. Well trained rats under baseline
conditions typically get most of their food by lever pressing,
and consume only small quantities of chow (Salamone et al.,
1991, 2002). Low-to-moderate doses of DA D1 or D2 receptor
antagonists produce a substantial shift in response allocation in
rats performing on this task, decreasing lever pressing for food
but substantially increasing intake of the concurrently available
chow (Salamone et al., 1991, 2002; Cousins et al., 1994; Sink et al.,
2008; Worden et al., 2009). This low-effort bias is also induced by
local intra-accumbens injections of DA antagonists, neurotoxic
depletions of accumbens DA, and tetrabenazine (Salamone et al.,
1991; Cousins et al., 1993; Koch et al., 2000; Nowend et al., 2001;
Farrar et al., 2010; Nunes et al., 2013a). As with the T-maze
task, the use of the concurrent FR5/chow feeding choice task
for assessing effort-related choice behavior has been validated
in many ways. For example, the low doses of DA antagonists
or tetrabenazine that produce the low-effort bias in effort-
based choice did not affect total food intake or alter preference
between these two specific foods in free-feeding choice tests
(Salamone et al., 1991; Nunes et al., 2013a). The effects of
DA antagonism or depletion were not mimicked by appetite
suppressants belonging to several different classes, including
amphetamine (Cousins et al., 1994), fenfluramine (Salamone
et al., 2002) and cannabinoid CB1 antagonists (Sink et al., 2008),
which failed to increase chow intake at doses that suppressed
lever pressing, and in fact tended to decrease chow intake. In
addition, reinforcer devaluation by pre-feeding to reduce food
motivation suppressed both lever pressing and chow intake
(Salamone et al., 1991). In more recent series of experiments, rats
were given a choice between lever pressing on a FR7 schedule for
a high concentration of sucrose vs. approaching and consuming
a less preferred lower concentration (Pardo et al., 2015). In
that study, tetrabenazine shifted choice behavior, decreasing
lever pressing but substantially increasing intake of the lower
concentration of sucrose that was concurrently available. These
effects of tetrabenazine were seen at doses that did not alter
preference between the two sucrose solutions, and did not
blunt the appetitive taste reactivity (sometimes referred to as
hedonic reactivity) induced by sucrose (Pardo et al., 2015). Taken
together, these findings demonstrate that interference with
DA transmission under conditions that suppress instrumental
actions does not simply reduce appetite or primary food
motivation. Rather, these manipulations alter the allocation of
instrumental responses in a manner that interacts with the
response requirement rather than the particular quality or
quantity of the food reinforcer. Thus, rodents with compromised
DA transmission still maintain fundamental aspects of food
motivation, and are still directed towards the acquisition and
consumption of food, but they have a low-effort bias and select
an alternative, less effortful path to obtain food.
EFFORT DISCOUNTING AND
PROGRESSIVE RATIO/CHOW FEEDING
CHOICE PROCEDURES OFFER INSIGHTS
INTO THE EFFORT-RELATED
MOTIVATIONAL FUNCTIONS OF DA
Effort Discounting Procedures
In addition to the behavioral tasks described above, several other
procedures have been developed in order to assess effort-related
motivational processes. Bardgett et al. (2009) developed an effort
discounting task based upon the T-maze barrier procedures, and
reported that D1 and D2 antagonism produced a low-effort bias.
Floresco et al. (2008b) studied the effects of the DA antagonist
flupenthixol using a discrete trial ratio discounting procedure
in which rats could either emit a single press to receive two
pellets (low-reward lever), or emit 2, 5, 10 or 20 responses to
obtain four pellets (high effort/high-reward lever). Flupenthixol
shifted effort discounting, reducing selection of the high effort
lever in a manner that was independent of any effects of delay of
reinforcement. In subsequent studies using this procedure it was
shown that the effects of DA D1 or D2 receptor antagonism were
characterized by actions on discounting based upon physical
effort (ratio discounting) but not cognitive effort discounting
(Hosking et al., 2015). To the extent that waiting for a reward
involves some type of cognitive effort, it is interesting to note that
local injections of DA antagonists into nucleus accumbens did
not affect progressive interval responding (Wakabayashi et al.,
2004). Robles and Johnson (2017) found that intraventricular
injection of the D2 antagonist eticlopride altered effort-based
decision making as assessed using a mouse two-lever choice task.
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Progressive Ratio Choice Procedures
Another procedure for assessing effort-based choice is a
variant of the lever pressing/chow feeding task, which employs
a progressive ratio (PROG) schedule as the lever pressing
component. In order to understand this task, it is useful to
provide some background on PROG operant schedules. With
PROG schedules, the ratio requirement increases as successive
ratios are completed, and responding continues until a ‘‘break
point’’ occurs, at which point the animal essentially ceases to
respond for a period of time. Determination of PROG break
points can be a very useful tool for characterizing some of the
actions of drugs that are self-administered, and for comparing
self-administration behavior across different drugs or drug
classes (e.g., Marinelli et al., 1998; Woolverton and Ranaldi,
2002). However, attaching conceptual or theoretical significance
to the results of studies involving PROG schedules can be
somewhat complicated. Although it is sometimes common to
see PROG break points used as a measure of ‘‘reward’’, it should
be emphasized that break points do not actually provide a simple
measure of the quality or quantity of a reinforcing stimulus in
a manner that is uncontaminated by other factors (Salamone
et al., 2009). In fact, drug or lesion-induced changes in PROG
break points can reflect much more than effects on the appetitive
motivational properties of a reinforcing stimulus (Arnold and
Roberts, 1997; Hamill et al., 1999). For example, response-
related factors such as changing the kinetic requirements of the
instrumental response (e.g., increasing the height of the lever)
was shown to decrease progressive ratio break points (Skjoldager
et al., 1993; Schmelzeis and Mittleman, 1996). Rather than
providing a direct or unambiguous measure of the appetitive
motivational characteristics of a stimulus, PROG break points
are more directly a measure of how much work the organism
will do in order to obtain that stimulus (Stewart, 1974). Thus,
it is reasonable to view PROG performance as resulting from
effort-related decision-making processes, in which the organism
is making a cost/benefit choice about whether or not to continue
to respond. Such choices are based in part on factors related to
characteristics of the reinforcer itself, and homeostatic factors,
but also involve assessments of the work-related response costs
and time constraints imposed by the ratio schedule (Salamone
et al., 2009).
Consistent with these concepts, effort-based decision-making
procedures have been developed that offer organisms a choice
between lever pressing on a PROG schedule to obtain a preferred
reinforcer vs. approaching and consuming the concurrently
available but relatively less preferred chow (Schweimer and
Hauber, 2005; Randall et al., 2012). Rats trained on this
procedure begin each session by pressing the lever, but as the
ratio requirement gradually increases, they eventually stop lever
pressing and switch to chow. In behavioral economic terms, the
chow is serving as a low-cost substitute that is obtained when the
response costs of lever pressing are too high; thus, the presence of
concurrently available chow suppresses the PROG lever pressing
(Figure 1). Because of the progressively incrementing work
requirement and the availability of a substitute, the baseline
level of lever pressing is relatively low for most animals (though
there is considerable variability; see below), and chow intake
FIGURE 1 | Effects of the availability of a food substitute on PROG lever
pressing output reinforced by high-carbohydrate pellets. As described in the
text, the PROG/chow feeding choice task is one of the behavioral procedures
that is used to assess effort-based choice in rodents (Randall et al., 2012,
2014; Yohn et al., 2016c). This figure presents baseline training data from
male Long Evans rats (n = 8) over the last 2 weeks of PROG alone training
(Weeks -2 and -1) followed by the first 2 weeks of PROG/chow feeding choice
training. As rats transition from the PROG alone schedule to the PROG/chow
feeding choice task, in which an alternative food source (laboratory chow) is
concurrently available in the chamber, it can be seen that the presence of the
available chow significantly suppresses lever pressing output (F(3,21) = 17.018,
p < 0.001). The available chow is acting like a low-cost substitute that shifts
demand away from the high-cost Bio-serv pellets that can only be obtained by
working on the PROG schedule.
is relatively high, compared to performance on the FR5/chow
feeding choice task. In the most commonly used version of this
task a time out is employed (Randall et al., 2012, 2014, 2015), so
that if the animal goes 2 min without receiving a reinforcement,
the lever pressing option is no longer reinforced. The highest
ratio achieved up to this time out thus serves as a measure that
is equivalent to the break point. In a sense, the PROG/chow
feeding choice procedure serves as a kind of ratio discounting
procedure, in which the animal lever presses up to a point and
then switches to the concurrently available chow when the lever
pressing requirement is too high.
In rats tested on the PROG/chow feeding choice task, lever
pressing and highest ratio achieved (i.e., break point) are
suppressed by administration of the DA D1 antagonist ecopipam
and the D2 antagonists haloperidol and eticlopride (Randall
et al., 2012, 2014). Although this result in itself may not be
viewed as very surprising given what is known about DA, what
is most important to consider is that despite these drug-induced
decreases in lever pressing, intake of the concurrently available
chow was not suppressed from its relatively high control levels,
and in fact tended to increase still further (Randall et al.,
2012, 2014). In contrast, the manipulations that fundamentally
blunt the reinforcing characteristics of food, such as reinforcer
devaluation by prefeeding, or administration of cannabinoid
receptor antagonists or inverse agonists that are known to act as
appetite suppressants (AM4113 and AM251), strongly suppress
both lever pressing and chow intake (Randall et al., 2012, 2014).
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FIGURE 2 | Schematic drawing summarizing the effects of various pharmacological manipulations on PROG/chow feeding choice performance. Interference with
dopamine (DA) transmission by giving DA antagonists or tetrabenazine decreases PROG lever pressing but does not suppress chow intake. In fact, chow intake was
significantly increased by the D1 antagonist ecopipam, and also increased in animals treated with haloperidol and tetrabenazine that had high baseline rates of lever
pressing (Randall et al., 2012, 2014). In contrast, interfering with the unconditioned reinforcing properties of food by reinforcer devaluation (pre-feeding) or by
administration of appetite suppressant drugs (CB1 receptor antagonists/inverse agonists) decreases both PROG lever pressing and chow intake. Finally, blockade of
adenosine A2A receptors or inhibition of DA uptake results in increased levels of PROG lever pressing (Randall et al., 2015; Yohn et al., 2016c).
Lever pressing work output is also attenuated by the VMAT-2
inhibitor and DA depleting agent tetrabenazine (Randall et al.,
2014), at doses that have no effect on food intake or preference
between the two foods used in the PROG/chow feeding choice
task (Nunes et al., 2013a). Thus, DA antagonism and depletion
are not reducing PROG lever pressing because of a general
suppression of the appetitvely motivating or unconditionally
reinforcing characteristics of food (Figure 2). Instead, these
manipulations effectively dissociate the tendency to work for
food from the unconditioned reinforcing value of food as
expressed by measures of intake and preference (Salamone et al.,
2016a,b,c, 2017).
Progressive Ratio Choice and Bidirectional
Dopaminergic Control of Effort-Based
Choice
Because of the relatively low baseline levels of lever pressing
emitted by rats responding on the PROG/chow feeding choice
task, this procedure provides an excellent baseline for assessing
the effects of drugs that have the potential to increase selection
of the high-effort PROG lever pressing (Figure 2). The
adenosine A2A receptor antagonist MSX-3, which has some of
the characteristics of minor stimulants such as caffeine, was
reported to increase PROG lever pressing and decrease chow
intake (Randall et al., 2012). A high effort bias (i.e., towards
PROG lever pressing) also has been seen after administration
of the catecholamine uptake blocker bupropion (Randall et al.,
2015), and the DA uptake blockers MRZ-9547 (Sommer et al.,
2014), lisdexamfetamine (Yohn et al., 2016e), PRX-14040 (Yohn
et al., 2016d) and GBR12909 (Yohn et al., 2016c). In contrast,
the norepinephrine (NE) uptake blockers desipramine and
atomoxetine and the 5-HT uptake blocker fluoxetine all failed to
increase PROG lever pressing, in fact tending to suppress lever
pressing (Yohn et al., 2016a).
These findings showing that pharmacological enhancement
of DA transmission can increase selection of high-effort
lever pressing illustrate the importance of DA transmission
as a bi-directional regulator of effort-based choice, which is
supported by research using non-pharmacological methods as
well. Previous studies have observed that there was enhanced
selection of high-effort instrumental actions in mice with
knockdown of DA transporters (Cagniard et al., 2006), and also
in mice that have increased expression of DA D2 receptors in
nucleus accumbens that was induced in adulthood (Trifilieff
et al., 2013). Recently, it was reported that selective chemogenetic
activation of mesolimbic DA neurons, but not nigrostriatal
neurons, increased responding for sucrose in rats responding on
a PROG schedule (Boekhoudt et al., 2018), an effect that was
characterized by increased initiation of bouts of instrumental
behavior. Fischbach-Weiss et al. (2018) found that optogenetic
inhibition of ventral tegmental area (VTA) DA neurons
suppressed both the initiation and the maintenance of effortful
operant responding on FR8 and PROG schedules. Furthermore,
individual differences in performance of high-effort activities
may be related to natural variations in DA transmission. As noted
above, PROG/chow feeding choice performance is characterized
by substantial individual differences that are very stable over
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time. Evidence indicates that rats with high PROG lever
pressing output had significantly higher levels of phosphorylated
DARPP-32 (DA and cAMP regulated phosphoprotein) in
nucleus accumbens core neurons compared to low responders
(Randall et al., 2012). This indicates that higher levels of
DA-related signal transduction in post-synaptic medium spiny
neurons are associated with a greater tendency to select
high-effort instrumental activities. It is not clear if this finding
represents a trait difference between high vs. low responders,
or is instead a marker of having emitted a large number of
responses. Nevertheless, an association between instrumental
response output and pre- or postsynaptic markers of DA-related
signaling, as seen in other studies (Sokolowski et al., 1998;
Segovia et al., 2011, 2012; Howe et al., 2013; Saddoris et al.,
2015; Hamid et al., 2016; Ko and Wanat, 2016; Wood et al.,
2017), provides additional evidence of the importance of DA
transmission in the regulation of response vigor and work output.
THE USE OF EFFORT-BASED CHOICE
TASKS AS PRECLINICAL TOOLS FOR
ANIMAL MODELS OF
PSYCHOPATHOLOGY
Impaired Behavioral Activation and
Effort-Related Decision-Making in
Psychopathology
As well as providing insights into the neurochemical regulation
of fundamental aspects of motivation, studies of effort-based
choice are being used for modeling motivational symptoms
seen in some psychiatric and neurological disorders. This
development has been influenced by several factors. First, it has
been recognized for some time that various psychopathologies
are associated with motivational dysfunctions that reflect a lack
of behavioral activation or low exertion of effort. In addition to
showing positive symptoms such as hallucinations and delusions,
schizophrenic patients also display negative symptoms that
include motivational dysfunctions (Gard et al., 2009). Depressed
patients have symptoms that include psychomotor retardation,
fatigue and anergia, which are very debilitating and are related
to a number of disease outcomes (Gullion and Rush, 1998;
Tylee et al., 1999). Fatigue is also commonly reported in
stroke patients (De Doncker et al., 2018) and people with
Parkinson’s disease (Chong et al., 2015). Generally speaking,
these motivational dysfunctions are highly treatment resistant.
For example, 5-HT uptake blockers that are commonly used
to treat depression are relatively ineffective at restoring normal
motivational function (Cooper et al., 2014; Fava et al., 2014;
Rothschild et al., 2014). Against this backdrop, there has been
a recent surge of research on humans that has specifically
focused on effort-related decision making, both in people with
various pathologies and healthy control participants. Wardle
et al. (2011) reported that amphetamine increased selection of
high-effort choices in healthy controls. Individual differences in
the selection of the high-effort choice were positively associated
with the degree of striatal DA release as measured by an
imaging marker (Treadway et al., 2012b). Mueller et al. (2018)
recently found that administration of α-methyltyrosine, which
inhibits catecholamine synthesis, disrupted the ability of healthy
control subjects to effectively integrate effort requirements and
reward availability. Furthermore, human studies have shown
that alterations in effort-based decision making are associated
with depression (Treadway et al., 2012a; Yang et al., 2014, 2016;
Culbreth et al., 2017), schizophrenia (Gold et al., 2013; Culbreth
et al., 2017) and Parkinson’s disease (Chong et al., 2015).
Animal Models of Effort-Related
Motivational Dysfunction
Based upon the foundation provided by animal research, as well
as the emerging clinical literature discussed above, formal animal
models of motivational pathologies have been developed, which
employ tasks assessing response vigor and effort-based decision
making (Salamone et al., 2006, 2015, 2016a,b,c; Simpson et al.,
2011, 2012; Markou et al., 2013; Bailey et al., 2016; Der-Avakian
et al., 2016). Some of this research has involved an assessment of
the effort-related effects in rodents of conditions associated with
depression in general, or with specific motivational symptoms
such as anergia and fatigue. Furthermore, potential drug
treatments have been a target for research in these models.
Because stress is such an important factor in psychopathology,
some studies have tried to determine the effects of stress on
effort-based choice. Restraint stress has been shown to induce
a low-effort bias as measured with an effort discounting task in
rats (Shafiei et al., 2012), and the effort-related effects of stress
involve the actions of corticotropin-releasing hormone (Bryce
and Floresco, 2016).
Another condition that has been used to induce a low-effort
bias in animal models is the VMAT-2 inhibitor tetrabenazine.
As described above, tetrabenazine is useful in research because
it is a pharmacological tool for depleting DA, however, it also
is used clinically to treat Huntington’s disease, and in this
context has been shown to induce psychiatric side effects in
humans such as depression and fatigue (Frank, 2009, 2010, 2014;
Guay, 2010). While tetrabenazine has been used to produce
deficits in classical animal models of depression such as the
forced swim test (Tadano et al., 2000; Wang et al., 2010), recent
studies have shown that tetrabenazine can induce a low-effort
bias in rats tested on the FR5/chow feeding choice (Nunes
et al., 2013b; Yohn et al., 2016b,d,e), PROG/chow feeding choice
(Randall et al., 2014), and T-maze barrier choice tests (Yohn
et al., 2015a,b). Control experiments conducted to validate
the use of tetrabenazine have shown that the effort-related
effects of tetrabenazine were not due to actions such as loss of
appetite, changes in preference for chow vs. pellets, or preference
across different concentrations of sucrose, discrimination of
reinforcement magnitude, hedonic reactivity for sucrose, or
reference memory (Nunes et al., 2013a; Randall et al., 2014;
Pardo et al., 2015; Yohn et al., 2015a). Given this pattern of
results, tetrabenazine clearly has considerable utility for inducing
effort-related deficits in animals, which can serve as a baseline
for identifying and characterizing potential drug targets for the
treatment of effort-related motivational symptoms (Salamone
et al., 2016a,b,c).
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Animal Models: Drug Development
Several monoamine uptake inhibitors are currently being used to
treat depression. 5-HT uptake blockers (i.e., SSRIs) are the most
commonly used antidepressants, and while they are effective at
treating mood dysfunction and rumination, they have limited
success in terms of restoring motivational function (Cooper
et al., 2014; Fava et al., 2014; Rothschild et al., 2014). Recent
experiments have been conducted to determine if monoamine
uptake inhibitors with different patterns of selectivity for 5-HT,
NE and DA uptake are able to reverse the effort-related
effects of tetrabenazine. Two commonly prescribed SSRIs are
fluoxetine and citalopram, and both of these drugs were unable
to attenuate the effects of tetrabenazine on FR5/chow feeding
choice performance (Yohn et al., 2016b,e). The NE transport
inhibitor desipramine also was studied, and like the SSRIs, it
was unable to reverse the effects of tetrabenazine (Yohn et al.,
2016b). Despite these negative results with inhibitors of 5-HT
and NE uptake, several DA uptake inhbitors have been shown
to be effective at reversing the effects of tetrabenazine on effort-
related decision making. Bupropion (Welbutrin) is widely used
as an antidepressant, and clinical studies have reported that
this catecholamine uptake inhibitor can be more effective than
SSRIs at treating fatigue symptoms (Papakostas et al., 2006;
Cooper et al., 2014). Recent animal studies have shown that
bupropion can reverse the effort-related effects of tetrabenazine
in rats tested on the T-maze barrier choice tasks (Yohn
et al., 2015a), as well as the FR5/chow feeding choice (Nunes
et al., 2013b; Yohn et al., 2016b), and PROG/chow feeding
choice tasks (Randall et al., 2014). Several other drugs that
are capable of inhibiting DA transport (GBR12909, PRX-14040,
lisdexamfetamine (Vyvanse), methylphenidate, and modafinil),
also have been reported to attenuate the effort-related effects of
tetrabenazine (Salamone et al., 2016c; Yohn et al., 2016b,d,e).
Consistent with these findings with animal models, human
studies have shown that amphetamine and methylphenidate, and
the atypical DA transport inhibitor modafinil, can have positive
effects on motivational symptoms in depressed patients (Stotz
et al., 1999; Lam et al., 2007; Ravindran et al., 2008).
As described above, the relatively low baseline levels of lever
pressing in animals tested on the PROG/chow feeding choice
task makes this procedure useful for assessing the potential
to increase selection of the high-effort PROG lever pressing.
This line of research provides important information about
the ability of drugs to produce a high-effort bias (i.e., to
enhance PROG output) in the absence of tetrabenazine. Sommer
et al. (2014) reported that the DA uptake inhibitor MRZ-9547
increased lever pressing in animals tested on the PROG/chow
feeding choice task. Furthermore, many of the drugs that
reverse the effort-related effects of tetrabenazine have been
shown to increase selection of lever pressing in rats tested
on the PROG/chow feeding choice procedure, including the
catecholamine uptake blocker bupropion (Randall et al., 2015),
and the DA uptake blockers lisdexamfetamine (Yohn et al.,
2016e), PRX-14040 (Yohn et al., 2016d) and GBR12909 (Yohn
et al., 2016c). As described above, these results highlight the role
of DA in modulating exertion of effort, but they also point to
dopaminergic manipulations as potential treatments for aspects
of motivational dysfunction (Salamone et al., 2016a). However,
neither the 5-HT uptake blocker fluoxetine nor NE transport
inhibitors desipramine and atomoxetine were able to increase
PROG lever pressing (Yohn et al., 2016a). Consistent with these
findings, atomoxetine also was reported to have no effect on
physical effort discounting (Hosking et al., 2015). Thus, despite
studies showing that locus ceruleus neuron activity increases
during exertion of physical effort (Varazzani et al., 2015), it does
not appear that augmenting NE transmission pharmacologically
increases selection of high effort activities. It is possible that
locus ceruleus NE neuron activity is a correlate of the peripheral
sympathetic activation during physical activity, or that it is
correlated with attentional or other cognitive processes that are
activated in parallel with the exertion of physical effort (Guillery
et al., 2017).
Taking these results together, it appears that studies of
effort-based decision making may ultimately contribute to
the development of novel drug treatments for motivational
dysfunction. In this regard, it is important to recognize that
animal models of effort-based choice are not strictly speaking
global models of depression, but instead are focused on modeling
a particular behavioral function, and its neural basis, which
may be relevant for understanding specific psychopathological
symptoms. Thus, this line of research is potentially relevant
for investigating motivational dysfunctions seen across many
different disorders (e.g., negative symptoms of schizophrenia;
see Simpson et al., 2011, 2012; Markou et al., 2013; Yohn et al.,
2017a). Such an approach is consistent with the NIH RDoC
(research domain criteria) initiative (Cuthbert and Insel, 2013),
which focuses on identifying the neural circuits that underlie
specific psychiatric symptoms.
SUMMARY, GENERAL CONCLUSIONS
AND BROADER IMPLICATIONS
As discussed above, considerable evidence indicates that
mesolimbic DA exerts a bi-directional control over exertion
of physical effort and effort-based choice. Interference with
DA transmission by DA antagonism or depletion produces
a low-effort bias in rodents tested on effort-based choice
tasks, while increasing DA transmission with drugs such
as DA transport blockers tends to enhance selection of
high-effort options. The results from these pharmacology
studies are consistent with findings from recent articles
using optogenetic, chemogenetic and physiological techniques.
Furthermore, although the present review has focused mainly
on drugs or neurotoxic lesions affecting mesolimbic DA
transmission, it is important to emphasize that other signaling
molecules in addition to DA, and several other brain areas, also
are involved in regulating behavioral activation, response vigor,
exertion of effort, and effort-based choice. These additional parts
of the circuitry include neuromodulators and neurotransmitters
such as adenosine (Font et al., 2008; Mingote et al., 2008; Farrar
et al., 2010; Nunes et al., 2010), acetylcholine (Nunes et al.,
2013b), and glutamate (Hutchison et al., 2017), and brain areas
including prefrontal/anterior cingulate cortex (Walton et al.,
2002, 2003, 2006; Schweimer and Hauber, 2005; Hart et al., 2017),
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and basolateral amygdala (Floresco and Ghods-Sharifi, 2007;
Hart and Izquierdo, 2017). The GABAergic ventral striatopallidal
pathway is a key connection in this circuitry (Mingote et al.,
2008). Injections of behaviorally effective doses of the DA
antagonist flupenthixol into nucleus accumbens core increases
extracellular GABA in lateral ventral pallidum (Salamone et al.,
2010), and injections of the GABA-A agonist muscimol into
lateral ventral pallidum produces a low-effort bias similar to
the effects of DA antagonism or depletion (Farrar et al., 2008;
Mingote et al., 2008). Furthermore, chemogenetic inactivation
of ventral striatopallidal neurons was reported to increase
responding on a PROG schedule in mice (Carvalho Poyraz
et al., 2016). In addition to acknowledging the distributed brain
network that regulates effort-based choice, it also is important
to recognize the role played by peripheral inflammation as a
factor involved in regulating effort-related aspects of motivation
(Nunes et al., 2014; Yohn et al., 2016a, 2017b).
Studies focusing on behavioral activation, response vigor and
effort-based choice also have had an impact on computational
neuroscience and economic models. Niv et al. (2007) offered
a model describing the relation between increased levels of
extracellular DA and response vigor. Phillips et al. (2007)
proposed that the role of DA in cost/benefit analyses can be
described by simple utility functions, and suggested that release
of DA opens a window of opportunistic drive, in which the
threshold cost expenditure to obtain reinforcers is decreased.
In recent years, there has been a proliferation of modeling
approaches that are intended to help characterize the roles
of effort exertion and reinforcement processing in motivated
behavior (Klein-Flügge et al., 2016; Białaszek et al., 2017;
Pessiglione et al., 2017; Vassena et al., 2017), and disentangle
exertion of effort from opportunity costs (Zénon et al., 2016). An
aspect of behavioral economics that is useful for understanding
the role of DA in effort-related aspects of motivation is the
concept of elasticity of demand (Salamone et al., 1997, 2016a,c,
2017). Price elasticity of demand for a commodity (e.g., a
reinforcer is a commodity in the context of operant behavior
experiments) refers to the effect of changes in price on demand
for that commodity. Low elasticity refers to a situation in
which the subject is relatively insensitive to price changes,
while higher levels of elasticity refers to conditions in which
the sensitivity to price is greater. As described above, one
way of controlling work-related response costs or prices in
experiments involving instrumental behavior is to vary the ratio
requirement of the lever pressing task. Previous work has shown
that neurotoxic depletions of accumbens DA make animals
more sensitive to the ratio requirements on ratio schedules
(Aberman and Salamone, 1999; Ishiwari et al., 2004), and this
type of effect has consistently been interpreted as representing
a role for DA in mediating elasticity of demand for food
(Salamone et al., 1997, 2009; Aberman and Salamone, 1999).
Although these earlier studies did not provide mathematical
indices of elasticity of demand, recent studies demonstrated
that low doses of the DA antagonist haloperidol and the
DA depleting agent tetrabenazine increased point elasticity of
demand (Salamone et al., 2017). Taken together, these findings
are consistent with a recent article reporting that DA D2 receptor
knockout also increased elasticity of demand (Soto et al.,
2016).
In addition to providing important basic science information
about the neural regulation of motivated behavior, effort-based
decision making research has several practical applications.
Within the fields of industrial/organizational psychology and
behavioral health, it is becoming more and more emphasized
that effort/reward trade-offs can be a substantial source of
stress in the workplace (Eddy et al., 2017, 2018). As reviewed
above, studies of effort-related decision making in humans
have the potential to offer important insights into motivational
dysfunction in psychopathology. Furthermore, tasks that assess
effort-based choice are useful for developing animal models of
some of the motivational symptoms that are seen in people with
various psychiatric and neurological disorders (e.g., depression,
schizophrenia and Parkinson’s disease). Exertion of effort in
pursuit of rewards is also a feature of drug self-adminitration
in humans and other animals (Vezina et al., 2002; Venugopalan
et al., 2011). Addicts will exert considerable effort to obtain
their preferred drug, and will overcome numerous obstacles
and constraints to do so. Furthermore, drug abstinence has
been shown to be associated with psychomotor retardation and
reduced selection of high-effort options in humans (Volkow
et al., 2001) and animal models (Thompson et al., 2017).
Although it is often the case that animal models are designed
to target neuropsychiatric disorders, it is nevertheless true
that most animal models provide behavioral phenotypes that
mimic specific symptoms or dysfunctions rather than entire
disorders. Studies of effort-related choice, in so far as they
contribute to animal models in psychiatry, are indeed designed to
focus on modeling specific symptoms and circuit dysfunctions,
and are not intended to provide global models of depression
or schizophrenia. Nevertheless, this line of work may offer
further insights into the neural circuits underlying motivational
dysfunction in humans, and may also lead to the identification
of drug targets that improve treatment outcomes for specific
motivational symptoms that can be highly problematic and
debilitating.
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